Tag:

WuXi PharmaTech

Latest Headlines

Latest Headlines

WuXi's manufacturing boom spells a big quarter

WuXi PharmaTech, China's largest CRO, boosted its revenue by 14.8% in the second quarter, as banner growth in its contract manufacturing business helped the company expand its global reach.

WuXi expands its Chinese ops as manufacturing brings in revenue

WuXi PharmaTech has increased its manufacturing capabilities in China, bolstering its fastest-growing business as it looks to expand around the globe.

Manufacturing continues to boost WuXi PharmaTech sales

More growth in its manufacturing operations helped pharma services company WuXi PharmaTech to another strong quarter.

WuXi wraps up construction on a new biologics shop

China's WuXi PharmaTech has completed work on a biologics safety testing facility in Suzhou, adding 38,000 square feet of lab space to its sprawling presence in the area.

WuXi scores more double-digit growth amid its global expansion

Chinese CRO WuXi PharmaTech notched another strong sales quarter, boosting its revenue by 11.3% thanks to escalating demand for its manufacturing services.

UPDATED: WuXi says it intends to triple capacity at China plant

The rapidly expanding pharma services company WuXi PharmaTech started work on a new facility in Philadelphia for manufacturing cell therapies last month. Now it says it is ready to undertake an expansion in China that will eventually triple its manufacturing capacity.

China's WuXi dials up its R&D presence at home and abroad

WuXi PharmaTech, China's largest CRO, is upping its capacity in its two largest markets, wrapping up an expansion of a U.S. early-stage operation and breaking ground on an R&D campus outside of Shanghai.

WuXi passes FDA muster in China and amps up its U.S. presence

Chinese outsourcing giant WuXi PharmaTech passed an FDA audit at one of its local facilities and broke ground on a new plant in the U.S., executing on its two-pronged strategy to take a bigger share of the global drug development market.

WuXi PharmaTech expands cell therapy manufacturing in U.S.

Chinese pharma services company WuXi PharmaTech reported 15% growth last year and said it expected to see similar growth this year. To maintain its momentum, the company has kicked off construction on a new facility in Philadelphia that will help achieve its expansion goals.

WuXi poaches an AstraZeneca exec to amp up Chinese R&D

Chinese CRO WuXi PharmaTech has convinced Steve Yang, head of Asian R&D for AstraZeneca, to jump ship, joining the company as it looks to expand its presence in its home country and abroad.